The transfer of technology along the entire value chain has a major influence on the success for innovations in biotechnology. Whether the “tongue as a sensor”, the development of regenerative therapies or new ways in drug development – at this year’s BioBalance, successful projects and new platforms for technology transfer from the Berlin-Brandenburg region are presented.
A special highlight will be the lecture Bioreactor systems “on demand” for the bioproduction of tomorrow by bbi-biotech CEO Bernd-Ulrich Wilhelm, which deals with the different approaches for the (fast) scalability of biotech production processes.
Of course, afterwards it will be possible to discuss different projects and trends in modern biotechnology.
Register here: http://www.healthcapital.de/termine/anmeldung/details/biobilanz-2017/register/25/
